The 25th China Biologics Conference (CBioPC 2026) will be grandly held at Nanjing International Expo Center from May 14 to 16, 2026. Centering on the high-quality development of the biomedical industry, it gathers academicians, experts, leading enterprises and industry elites to discuss innovation trends and achievement transformation in frontier fields including vaccines, cell and gene therapy, recombinant therapeutic products and biopharmaceutical engineering.

Boasting over 30 years of technical experience, full-spectrum service capabilities, stringent compliance systems and seasoned expert teams, JOINN supports the entire lifecycle of drug R&D. It consistently helps biomedical enterprises tackle R&D challenges, shorten development cycles and ensure regulatory compliance, fully facilitating the launch of innovative drugs and driving the innovative upgrading of China’s biomedical industry.